hsa-miR-199b-3p suppresses osteosarcoma progression by targeting CCDC88A, inhibiting epithelial-to-mesenchymal transition, and Wnt/beta-catenin signaling pathway
Crossref DOI link: https://doi.org/10.1038/s41598-023-39537-0
Published Online: 2023-08-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zhu, Dongsheng
Qi, Han
Zhu, Hongqi
Text and Data Mining valid from 2023-08-02
Version of Record valid from 2023-08-02
Article History
Received: 12 March 2023
Accepted: 26 July 2023
First Online: 2 August 2023
Competing interests
: The authors declare no competing interests.